Cryo Cell International (CCEL) Revenue (2010 - 2026)

Cryo Cell International (CCEL) has reported Revenue for 17 consecutive years, with $7.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Revenue fell 1.93% year-over-year to $7.8 million; the TTM figure through May 2026 stood at $31.1 million (down 2.69% YoY), while the FY2025 annual figure was $31.6 million, down 1.31% from the prior year.
• Revenue rose to $7.8 million in Q2 2026 per CCEL's latest filing, from $7.7 million in the prior quarter.
• Across five years, Revenue topped out at $8.1 million in Q3 2024 and bottomed at $7.3 million in Q1 2022.
• Historically, Revenue has averaged $7.8 million across 5 years, with a median of $7.8 million in 2025.
• Annual changes were most pronounced in 2023 — Revenue climbed 7.8% — and 2026, when it retreated 3.59%.
• Cryo Cell International's Revenue stood at $7.8 million in 2022, then climbed by 1.45% to $7.9 million in 2023, then increased by 1.87% to $8.0 million in 2024, then slipped by 2.26% to $7.8 million in 2025, then slipped by 0.85% to $7.8 million in 2026.
• Business Quant data shows CCEL's Revenue at $7.8 million in Q2 2026, $7.7 million in Q1 2026, and $7.8 million in Q4 2025.